Bibliographic Details
| Title: |
Editorial: The Complexity of Neurofeedback and Control of Placebo Effects. |
| Authors: |
Aggensteiner, Pascal-M.1 (AUTHOR) Pascal.Aggensteiner@zi-mannheim.de |
| Source: |
Journal of the American Academy of Child & Adolescent Psychiatry. Jul2021, Vol. 60 Issue 7, p811-812. 2p. |
| Subject Terms: |
*Biofeedback training, *Attention-deficit hyperactivity disorder, Placebos, Clinical trials, Treatment of attention-deficit hyperactivity disorder |
| Abstract: |
The Neurofeedback Collaborative Group1 made substantial efforts in assessing clinical effects of neurofeedback (NF) as a promising nonpharmacological treatment option for attention-deficit/hyperactivity disorder (ADHD). In a double-blind, placebo-controlled randomized clinical trial (RCT), they evaluated the specific effects of a standard NF protocol (theta/beta ratio [TBR] training) compared to a placebo-like control group. Similar to pharmacological studies, the placebo-like intervention can be considered as a gold standard, as it allows evaluation of specific effects of NF training. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of the American Academy of Child & Adolescent Psychiatry is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Education Research Complete |
